Fidelity Investments’s Intelligent Bio Solutions INBS Stock Holding History

Fidelity Investments’s Portfolio INBS Stock Details INBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4	Closed	-$4K	–	5474
2022 Q3	$4K	Buy	+4	New	+$6.06K	﹤0.01%	4392

Other funds holding INBS

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Fidelity Investments's INBS Position: Q4 2022 in Review

Fidelity Investments sold out of Intelligent Bio Solutions (INBS) in Q4 2022, closing a stake of 4 shares — an estimated $4K sold.

Fidelity Investments first reported a position in INBS in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 8 funds tracked by Wall St. Rank hold INBS as of Q4 2022.

Fidelity Investments reported no remaining Intelligent Bio Solutions position as of Q4 2022 after selling out during the quarter.
Fidelity Investments sold 4 Intelligent Bio Solutions shares in Q4 2022, an estimated $4K.
Fidelity Investments first reported a position in Intelligent Bio Solutions in Q3 2022 and held it in 1 quarter.
Fidelity Investments's Intelligent Bio Solutions position peaked at $4K in Q3 2022.
8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q4 2022.

Based on Fidelity Investments's 13F filing for Q4 2022, filed 13 Feb 2023.